Resource Library / Assessing Pre-Existing Antibodies (PEXA) in Biotherapeutic Development

white-paper

Assessing Pre-Existing Antibodies (PEXA) in Biotherapeutic Development

A patient may have pre-existing antibodies (PEXA) to a therapeutic, which can impact the immune response to the drug in question. In this paper, we discuss the nature of PEXAs, how they can be detected and characterized, and how sponsors should proceed when they are present.

Register to gain access to gated resources.

"*" indicates required fields

URL

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*

Country

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.